Latin America Colorectal Cancer Market By Diagnosis (Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy), By Treatment (Surgery And Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance To Pharmacological Therapies), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)
Latin America Colorectal Cancer Market By Diagnosis (Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy), By Treatment (Surgery And Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance To Pharmacological Therapies), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018–2023)
ID: 615 | Pages: 132 | April 2018 | Region: Latin America
The Latin America Colorectal Cancer Market was worth $2.21 billion in 2018 and estimated to be growing at a CAGR of 2.10%, to reach $2.36 billion by 2023. Though there has been substantial development in science and technology to combat cancer, it continues to threaten lives across the globe.
Colorectal cancer is identified with a biopsy, which then followed by medical imaging to know its extent. Depending on the stage and how much the cancer has expanded, a combination of radiation therapy, chemotherapy, and targeted therapy is recommended by most oncologists.
The growth of the Latin America Colorectal Cancer Market is mainly driven by factors such as rise in aging population, and government policies to provide better care for Colorectal Cancer. However, factors such as high costs of screening tests and poor accessibility of proper health care in this part of the world are hindering the growth of the market.
The Latin America Colorectal Cancer market is segmented based on Diagnosis and Treatment. The market for Colorectal Cancer, on the basis of Diagnosis is segmented into Digital Rectal Examination, Faecal Occult Blood Test, Flexible Sigmoidoscopy, Colonoscopy, Virtual Colonoscopy. On the basis of Treatment, the global Colorectal Cancer market is segmented into Surgery and Radiation Therapy, Chemotherapy, Targeted Therapies, Resistance to Pharmacological Therapies.
Latin America market region includes countries such as Brazil, Mexico, Argentina, and remaining countries of South America. Brazil accounts for the major part of the Colorectal Cancer market in this region followed by Argentina. Other significant markets in this region are Uruguay, Paraguay, Colombia, Chile, and Bolivia.
Some of the major companies dominating this market are Abbott Diagnostics, Alere, Beckman Coulter, Clinical Genomics, Companion Dx, Hoffmann La Roche, Debiopharm Group, Vaccinogen BD.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Diagnosis
5.1.1 Digital Rectal Examination
5.1.2 Faecal Occult Blood Test
5.1.3 Flexible Sigmoidoscopy
5.1.4 Colonoscopy
5.1.5 Virtual Colonoscopy
5.2 By Treatment
5.2.1 Surgery and Radiation Therapy
5.2.2 Chemotherapy
5.2.3 Targeted Therapies
5.2.4 Resistance to Pharmacological Therapies
6. Geographical Analysis
6.1 Introduction
6.2 Brazil
6.3 Argentina
6.4 Mexico
6.5 Rest of Latin America
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Abbott Diagnostics
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 Alere
8.3 Beckman Coulter
8.4 Clinical Genomics
8.5 Companion Dx
8.6 Hoffmann La Roche
8.7 Debiopharm Group
8.8 Vaccinogen BD
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
- Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
- Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
- Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
- Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
- Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
- A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
- Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
- An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
- Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
| Title | Price | Add To Cart |
- Latin America Colorectal Cancer Market By Region, From 2018-2023 (USD Billion)
- Latin America Colorectal Cancer Market By Diagnosis, From 2018-2023 (USD Billion)
- Latin America Digital Rectal Examination Market By Region, From 2018-2023 (USD Billion)
- Latin America Faecal Occult Blood Test Market By Region, From 2018-2023 (USD Billion)
- Latin America Flexible Sigmoidoscopy Market By Region, From 2018-2023 (USD Billion)
- Latin America Colonoscopy Market By Region, From 2018-2023 (USD Billion)
- Latin America Virtual Colonoscopy Market By Region, From 2018-2023 (USD Billion)
- Latin America Colorectal Cancer Market By Treatment, From 2018-2023 (USD Billion)
- Latin America Surgery and Radiation Therapy Market By Region, From 2018-2023 (USD Billion)
- Latin America Chemotherapy Market By Region, From 2018-2023 (USD Billion)
- Latin America Targeted Therapies Market By Region, From 2018-2023 (USD Billion)
- Latin America Resistance to Pharmacological Therapies Market By Region, From 2018-2023 (USD Billion)
- Brazil Colorectal Cancer Market By Diagnosis, From 2018-2023 (USD Billion)
- Brazil Colorectal Cancer Market By Treatment, From 2018-2023 (USD Billion)
- Argentina Colorectal Cancer Market By Diagnosis, From 2018-2023 (USD Billion)
- Argentina Colorectal Cancer Market By Treatment, From 2018-2023 (USD Billion)
- Mexico Colorectal Cancer Market By Diagnosis, From 2018-2023 (USD Billion)
- Mexico Colorectal Cancer Market By Treatment, From 2018-2023 (USD Billion)
Licence Type 
Clients
Why buy reports from Market Data Forecast
Free Customization
Free report customization that helps you gain required information for always being one step ahead of the competition
Post Purchase Support
6 months of post purchase support via email and phone; serving your needs 24x7 and helping you troubleshoot any technical issues
Best Price guaranteed
Customer focused research services and expertly devised strategic analyses made into premium quality reports at lowest prices
Insightful Snapshots
Summarized overviews of entire reports into customized presentations to ascertain market estimations and driving forces at a quick glance